Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer

NCT00928174 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: IV administration of fluorine-18 fluorocholine followed by PET/CT imaging

Sponsor

Queen's Medical Center

Collaborators

[object Object]